|
|
|
23.04.26 - 13:03
|
LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor (Business Wire)
|
|
|
Precision diagnostics company adds seasoned oncology and diagnostics leaders to advance noninvasive tumor microenvironment profilingSAN CARLOS, Calif.--(BUSINESS WIRE)--LiquidCell Dx, a precision diagnostics company building a blood-based platform for tumor microenvironment profiling, today announced the appointment of Mirna Jarosz as Chief Executive Officer and Vincent A. Miller, MD, as Senior Strategic Advisor. The appointments add operating, commercialization and clinical leadership as the company advances its platform and prepares for the next stage of growth.
Comprehensive genomic profiling changed oncology by making the tumor readable from blood. The biology around the tumor, including the immune cells, stromal context, and multicellular environment that shapes whether a drug works, has remained largely out of reach in routine clinical care. LiquidCell Dx is building a platform to change that, and has assembled an experienced team to bring it to market.
Jarosz has been a founding-stage operator acro...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
